NASDAQ:SBPH Spring Bank Pharmaceuticals (SBPH) Stock Price, News & Analysis → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free SBPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$1.21▼$10.3952-Week Range N/AVolumeN/AAverage Volume177,606 shsMarket Capitalization$122.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Spring Bank Pharmaceuticals alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Spring Bank Pharmaceuticals Stock (NASDAQ:SBPH)Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for the treatment of a range of cancers and inflammatory diseases using its proprietary small molecule nucleotide platform. The company is developing SB 11285, a next-generation immunotherapeutic cyclic dinucleotide for the treatment of selected cancers; novel STING antagonist compounds for the treatment of autoimmune and inflammatory diseases; and novel platform to enable the targeted delivery of payload molecules. It has a collaboration agreement with with Roche to explore the co-administration of SB 11285. The company was formerly known as Spring Bank Technologies, Inc. and changed its name to Spring Bank Pharmaceuticals, Inc. in May 2008. Spring Bank Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Hopkinton, Massachusetts.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… SBPH Stock News HeadlinesJanuary 31, 2024 | thetimes.co.ukWhen will interest rates go down?January 6, 2024 | ca.finance.yahoo.comBank of Canada expected to 'cautiously' start cutting rates in spring: Deloitte CanadaApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.September 29, 2023 | hulldailymail.co.ukMan stabbed during street fight in Spring Bank WestAugust 8, 2023 | hulldailymail.co.ukSpring Bank fight involved two feuding families, police believeAugust 8, 2023 | hulldailymail.co.ukCalls for more police patrols on Spring Bank after fight leaves three in hospitalAugust 7, 2023 | hulldailymail.co.ukSpring Bank fight: Six men and a woman held over shocking street violenceAugust 5, 2023 | hulldailymail.co.ukThe mysterious structure on Spring Bank created to shoot out a beam of lightApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.June 30, 2023 | hulldailymail.co.ukHull's Spring Bank set for major regeneration as plans announced to make it more 'attractive'June 14, 2023 | forbes.comSpring 2023 Layoff Tracker: Grubhub Cuts 400 StaffMay 20, 2023 | uk.news.yahoo.comWhen is the the next UK Bank Holiday and how many are left in 2023?March 26, 2023 | cbsnews.comBest St. Patrick's Day deals on Amazon: Save big on spring cleaning, Apple tech and moreMarch 22, 2023 | cbsnews.comMiami Beach enacts spring break curfew after 2 fatal shootingsMarch 20, 2023 | nytimes.comSpring ReturnsMarch 18, 2023 | nypost.comFlorida fight club: Scantily clad spring break revelers let out pent-up rage in boozy beach brawlsJanuary 22, 2023 | duluthnewstribune.comSt. Scholastica to open spring practiceOctober 31, 2022 | msn.comPartying street protesters forced Spring Bank to closeOctober 9, 2022 | forbes.comSpring Bank PharmaceuticalsJuly 30, 2022 | finance.yahoo.com‘Pharma bro’ Martin Shkreli is fresh out of prison with a new Web3-crypto ‘drug discovery’ businessJuly 10, 2022 | finance.yahoo.comSpringfield-area consumers get some relief at the pump as prices drop below $5December 29, 2021 | fool.comSpring Bank Pharmaceuticals(SBPH)See More Headlines Receive SBPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Spring Bank Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2020Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SBPH CUSIPN/A CIK1566373 Webwww.springbankpharm.com Phone508-473-5993FaxN/AEmployees30Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.47) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-24,100,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-89.89% Return on Assets-52.89% Debt Debt-to-Equity RatioN/A Current Ratio5.11 Quick Ratio5.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.16 per share Price / BookN/AMiscellaneous Outstanding Shares17,267,000Free FloatN/AMarket Cap$122.94 million OptionableNot Optionable Beta1.07 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Martin J. Driscoll (Age 61)Pres, CEO & Director Comp: $568.08kDr. Radhakrishna P. Iyer Ph.D. (Age 70)FRSC, Co-Founder & Chief Scientific Officer Comp: $452.04kMs. Lori C. Firmani (Age 47)VP of Fin., Treasurer, Principal Financial Officer & Principal Accounting Officer Mr. Donald Mitchell MBAVP of Operations & Corp. Devel.Mr. Garrett Winslow (Age 41)VP of Legal, Sec. & Gen. Counsel Dr. Nezam H. Afdhal (Age 63)Chief Medical Officer Dr. Atif AbbasVP and Head of Oncology & Immunology Clinical Devel.More ExecutivesKey CompetitorsCitius PharmaceuticalsNASDAQ:CTXRRepare TherapeuticsNASDAQ:RPTXKaryopharm TherapeuticsNASDAQ:KPTIEmergent BioSolutionsNYSE:EBSGlycoMimeticsNASDAQ:GLYCView All Competitors SBPH Stock Analysis - Frequently Asked Questions How were Spring Bank Pharmaceuticals' earnings last quarter? Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) released its quarterly earnings data on Sunday, November, 8th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.06. What other stocks do shareholders of Spring Bank Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Spring Bank Pharmaceuticals investors own include Intelsat (I), AMC Entertainment (AMC), Bank of America (BAC), Fossil Group (FOSL), Associated British Foods (ABF), Apollo Global Management (APO), Chaarat Gold (CGH), SCYNEXIS (SCYX), Avadel Pharmaceuticals (AVDL) and China Unicom (Hong Kong) (CHU). When did Spring Bank Pharmaceuticals IPO? Spring Bank Pharmaceuticals (SBPH) raised $14 million in an initial public offering on Friday, May 6th 2016. The company issued 1,100,000 shares at $12.00-$14.00 per share. Dawson James Securities served as the underwriter for the IPO. This page (NASDAQ:SBPH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spring Bank Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
